Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Analysis: The Fed’s First Real Rate Cut May Come Next Year, Slight Decline Expected by Year-End

Analysis: The Fed’s First Real Rate Cut May Come Next Year, Slight Decline Expected by Year-End

BlockBeatsBlockBeats2025/07/08 20:02
Show original

BlockBeats News, July 8 — Brendan Murphy, Head of Fixed Income at Insight Investment, stated in a report that U.S. interest rates may decline slightly before the end of this year, but substantial rate cuts are expected to occur next year.


Although the economic outlook is weakening, recent inflationary pressures caused by U.S. trade tariffs will make the Federal Reserve’s policy response more complex. In this context, the Fed is expected to adopt a cautious approach.


The institution anticipates that after inflationary pressures ease and growth concerns become the dominant factor in 2026, the Federal Reserve will take more decisive rate-cutting actions. (Jin10)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas